Actively Recruiting

Phase 2
Age: 18Years - 80Years
All Genders
NCT07100418

A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia

Led by Fujian Shengdi Pharmaceutical Co., Ltd. · Updated on 2025-09-10

200

Participants Needed

1

Research Sites

72 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study is being conducted to evaluate the efficacy and safety of HRS-7249 for patients with hyperlipidemia, and to explore the reasonable dosage of HRS-7249 for patients with hyperlipidemia.

CONDITIONS

Official Title

A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Able and willing to provide a written informed consent.
  • Age  18 years old and < 80 years old.
  • Male or female.
Not Eligible

You will not qualify if you...

  • Acute pancreatitis within 3 months or within 4 weeks or planned for plasma exchange treatment.
  • Malignant tumors within 5 years.
  • Severe cardiovascular or cerebrovascular diseases.
  • Severe trauma or surgery within 6 months or severe infection within 3 months.
  • Previous diagnosed diseases affecting lipid levels.
  • Patients with unstable or severe diseases assessed as at risk by the investigator.
  • Uncontrolled hypertension.
  • Weight loss within 2 months or planned surgery causing unstable weight.
  • Uncontrolled diabetes.
  • Combined hyperthyroidism or hypothyroidism.
  • History of drug or alcohol abuse.
  • Significantly abnormal liver or kidney function.
  • Significantly abnormal blood routine.
  • Significantly abnormal thyroid function.
  • Participated in clinical research within 3 months.
  • Pregnant or lactating women, or refusing contraception.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Shanghai Chest Hospital

Shanghai, Shanghai Municipality, China, 200030

Actively Recruiting

Loading map...

Research Team

C

Chanjuan Deng

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia | DecenTrialz